Mycronic AB (publ) provides sales guidance for the full year 2022. The Board of Directors' opinion that consolidated net sales for 2022 will be at a level of SEK 5 billion, based on exchange rates at the end of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
437 SEK | +1.16% |
|
+5.81% | +52.05% |
08/05 | Mycronic AB Approves Dividend, Payable on May 16, 2024 | CI |
02/05 | Mycronic AB Receives the First Order for an MMX Metrology System | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+52.05% | 4.05B | |
+39.80% | 401B | |
+32.27% | 135B | |
+38.39% | 102B | |
+22.96% | 22.13B | |
+11.75% | 20.19B | |
+43.53% | 10.81B | |
+24.48% | 9.16B | |
+4.78% | 8.58B | |
-23.72% | 6.06B |
- Stock Market
- Equities
- MYCR Stock
- News Mycronic AB
- Mycronic AB Provides Sales Guidance for the Full Year 2022